Insights

  • Home
  • Insights
  • Federal Circuit Holds Objective Indicia Must Be Linked to Novel Features, PTAB Litigation Blog

Share

Federal Circuit Holds Objective Indicia Must Be Linked to Novel Features, <i>PTAB Litigation Blog</i>

Federal Circuit Holds Objective Indicia Must Be Linked to Novel Features, PTAB Litigation Blog

May 09, 2017 Blog

Visit the Jones Day PTAB Litigation.

In Novartis AG v. Torrent Pharms. Ltd. (2016-1352), the Federal Circuit affirmed the PTAB’s decision in consolidated IPR proceedings (IPR2014-00784, IPR2015-00518) invalidating all claims of U.S. Patent 8,324,283. In doing so, the court affirmed the PTAB’s finding that Novartis’ evidence on the objective indicia of nonobviousness lacked sufficient nexus to the claimed invention to warrant a different outcome.

Read the full article at ptablitigationblog.com.

You May Also Be Interested In

December 20, 2024 Alert

New Year, New Fees: USPTO Surcharges and Fee Increases for Trademark Filings in 2025

December 20, 2024 Blog

PTAB Reiterates Strict Evidentiary Standard for Printed Publications, PTAB Litigation Blog

December 19, 2024 Commentary

French CSPLA Report Highlights AI Regulation: Transparency and Copyright Compliance in Focus

December 19, 2024 Commentary

Trademark Scams 101: Common Signs of Scams and How to Avoid Them

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.